Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this clinical trial was to determine the time to improvement of the
signs and symptoms (eg, dysuria, frequency, urgency, gross hematuria, suprapubic pain,
hesitancy, low back pain) of acute, uncomplicated, symptomatic, lower UTIs in women treated
with Cipro XR 500 mg once daily for 3 days.